SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
ABIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.91%81.791.6%$917.74m
BIIBBiogen Inc.
0.46%288.351.2%$563.58m
AMGNAmgen Inc.
1.80%170.681.2%$484.60m
CELGCelgene Corporation
1.82%108.111.1%$483.92m
REGNRegeneron Pharmaceuticals, Inc.
4.22%415.093.1%$314.35m
ALXNAlexion Pharmaceuticals, Inc.
2.47%129.782.6%$250.20m
BMRNBioMarin Pharmaceutical Inc.
6.60%98.093.9%$221.31m
TSROTESARO, Inc.
3.70%93.3818.0%$220.10m
ILMNIllumina, Inc.
8.10%162.255.1%$184.65m
VRTXVertex Pharmaceuticals Incorporated
1.08%96.011.7%$136.85m
MDVNMedivation, Inc.
-0.14%62.552.6%$124.28m
JUNOJuno Therapeutics, Inc.
-0.49%30.377.9%$105.68m
EXASExact Sciences Corporation
3.76%16.8228.8%$94.88m
AAgilent Technologies, Inc.
0.68%47.271.9%$89.23m
INCYIncyte Corporation
2.02%88.722.2%$76.74m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.